• Profile
Close

Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma

Human Pathology Mar 31, 2019

Meyer SN, et al. - In this investigation, researchers identified the frequency of cytokeratin (CK)+/vimentin (VIM)+ tumor cells and described the CK+/VIM+ stroma in colorectal cancer. Using DepArray and fluorescence-activated cell sorting (FACS), three cell populations (CK+, VIM+, CK+/VIM+) were sorted. To visualize co-expressing cells on whole slides, fluorescence microscopy was used. Investigators found that a low proportion of CK+/VIM+ tumor cells (1.5%–22%). Findings suggested CK+ stroma was associated with aggressive tumor features, like distant metastasis, lymphatic invasion and tumor budding. Although in low numbers, CK+/VIM+ tumor cells may represent a subgroup of tumor buds in partial epithelial-mesenchymal transition. CK+/VIM+ stroma can be mesothelial and shows the characteristics of mesenchymal cells and fibroblasts associated with cancer. These outcomes suggest that there is a mesothelial-mesenchymal transition (MMT) of double-positive fibroblast. This atypical stroma can be a potential therapeutic target.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay